A Study of the Dose Proportionality of Extended Release Paliperidone

Summary

The purposes of this study are to evaluate the dose proportionality of 1.5- and 3 mg tablets of paliperidone ER, to document the pharmacokinetics of a 1.5 mg dose of paliperidone ER, and to assess the safety and tolerability of the 1.5- and 3 mg tablets in healthy men.

Timeline

Start

2006-06

Primary completion

—

Completion

2006-08

Drugs

Indications